Hypertension has been shown to be associated with impaired endothelium-derived hyperpolarizing factor (EDHF)-mediated arterial relaxation and hyperpolarization. Treatments of hypertensive rats with inhibitors of the renin-angiotensin system have been shown to restore both EDHF-mediated responses and the expression of connexins involved in the intercellular transfer of the hyperpolarization in mesenteric arteries. The present study was designed to determine whether chronic treatment of rats with angiotensin II impairs EDHF-mediated responses and the expression of connexins in the mesenteric arterial wall. Male Wistar rats were treated with angiotensin II (0.4 mg/kg/day) for 21 days using osmotic minipumps. Arterial pressure was measured by tail-cuff plethysmography. Contractile responses and membrane potential were measured in isolated mesenteric arteries. The expression of the three connexins (Cxs), Cx37, Cx40, and Cx43, was quantified in segments of mesenteric arteries by immunohistochemistry and quantitative real-time reverse transcriptase-polymerase chain reaction. Angiotensin II administration increased the mean systolic blood pressure. EDHF-mediated relaxation and hyperpolarization to acetylcholine and red wine polyphenols were significantly impaired in mesenteric arteries from angiotensin II-treated rats in comparison with control animals, whereas nitric oxide-mediated relaxation was unaltered. The expression of connexins Cx37, Cx40, and Cx43 was significantly decreased in the mesenteric artery from angiotensin II-treated rats. These findings indicate that angiotensin II-induced hypertension is associated with a selective impairment of EDHF-mediated relaxation and hyperpolarization in the rat mesenteric artery. The inhibition of EDHF-mediated responses is due, at least in part, to a decreased expression of connexins Cx37, Cx40, and Cx43 in the arterial wall.
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Endothelial cells play a major role in the control of vascular homeostasis, in part by the production and release of vasorelaxing factors. Among these factors contributing to the protective effect of endothelial cells are NO (Furchgott and Zawadzki, 1980; Palmer et al., 1987) , prostacyclin (Moncada and Vane, 1978) , and the endothelium-derived hyperpolarizing factor (EDHF), which is associated with hyperpolarization of vascular smooth muscle cells (for review, see Busse et al., 2002; Félétou and Vanhoutte, 2006) . In most cases, this hyperpolarization reflects the activation of endothelial small and intermediate conductance calcium-activated potassium channels.
Although EDHF plays only a minor role in the control of vascular tone in most large arteries in contrast to NO, its importance increases as the vessel size decreases (Shimokawa et al., 1996) . In addition, the nature of EDHF has been the matter of much debate. It is now accepted that EDHF may vary according to the arterial bed and animal species investigated (for review, see Busse et al., 2002; Félé-tou and Vanhoutte, 2006) . Besides epoxyeicosatrienoic acids (Fisslthaler et al., 1999) , hydrogen peroxide (Matoba et al., 2000) , and potassium ions (Edwards et al., 1998) , gap junctions provide a satisfactory explanation in several vessels for the propagation of endothelial hyperpolarization to the underlying smooth muscle cells, which characterizes EDHFmediated responses in arteries (Griffith et al., 2004) . In many arteries, these pathways may operate in parallel, and, for instance, in the rat mesenteric artery, during submaximal contraction to phenylephrine, myoendothelial gap junctions and endothelium-derived K ϩ ions support EDHF-mediated responses (Edwards et al., 1998; Dora et al., 2003) . Hydrogen peroxide is a rather weak relaxing and hyperpolarizing factor; in addition, if epoxyeicosatrienoic acids are endotheliumderived hyperpolarizing factors, principally in porcine and bovine coronary arteries, they may also regulate endothelial calcium homeostasis and the activity of endothelial calciumactivated potassium channels and modulate gap junctional communication (for review, see Félétou and Vanhoutte, 2006) .
The physiological role of gap junctional intercellular communication has been particularly well investigated in vascular smooth muscle in which cellular propagation of an electrical or a chemical signal through gap junctions plays a key role in the conduction of vasomotor responses, rapidly propagating vasodilatation or vasoconstriction (Christ et al., 1996) . In blood vessels, gap junctions allow the direct coupling between adjacent endothelial cells or adjacent smooth muscle cells or even connect endothelial to smooth muscle cells in structures corresponding to myoendothelial gap junctions. At least three connexins (Cxs) are involved in the formation of vascular gap junctions, Cx37, Cx40, and Cx43 (Christ et al., 1996; Hill et al., 2002) . A close correlation between the distribution of myoendothelial gap junctions along the mesenteric arterial tree and EDHF-mediated responses has been suggested (Sandow and Hill, 2000) . The functional role of gap junctions in EDHF-mediated responses has been confirmed in the rat mesenteric artery (Edwards et al., 1999; Sandow et al., 2002; Mather et al., 2005) and in other arteries.
Hypertension is often associated with endothelial dysfunction (Mombouli and Vanhoutte, 1999) . Several studies suggest that there is a close association between altered connexin expression in the arterial wall, changes in the reninangiotensin system, and hypertension. However, until now, a clear demonstration of an effect of angiotensin II, the most active component of the renin-angiotensin system, on vascular connexin expression is still missing. Therefore, our study aimed to determine whether there is an alteration of EDHFmediated responses and a modification of connexin expression in the arterial wall in response to chronic angiotensin II administration to rats.
EDHF-mediated responses were induced, ex vivo in the rat mesenteric artery, by two independent stimuli, acetylcholine and red wine polyphenols (RWPs). Acetylcholine is mainly dependent on an increase in intracellular free calcium concentration in endothelial cells. RWPs have been shown to induce arterial relaxations, mainly through the redox-sensitive activation of the PI3-kinase pathway (Ndiaye et al., 2004 (Ndiaye et al., , 2005 . Therefore, we sought to verify whether angiotensin II is able to discriminate the two distinct endothelial intracellular pathways in response to the two stimuli, acetylcholine and RWPs.
Materials and Methods
In Vivo Treatment of Rats with Angiotensin II. This study was approved by the local ethics committee of animal experimentation (Comité Régional d'Ethique en Matière d'Expérimentation Animale, Strasbourg, France). Male Wistar rats (12 weeks old) were anesthetized with intraperitoneal administration of ketamine (80 mg/kg) and xylazine (10 mg/kg). A 1-cm-long incision was made in the midscapular region, and an osmotic minipump (Alzet, model 2004) was implanted. Angiotensin II, contained in the osmotic minipumps, was dissolved in 0.15 mM NaCl containing 0.01 N acetic acid as described previously (Sarr et al., 2006) . The infusion rate was 0.4 mg/kg/day. Control rats were age-matched animals, which underwent an identical surgical procedure without pump implantation. After 21 days of angiotensin II administration, rats were euthanized; thereafter, blood was taken into EDTA-containing tubes from the abdominal aorta. Blood was centrifuged at 4°C for 10 min at 2000g. Plasma samples were then frozen in liquid nitrogen and stored at Ϫ80°C for a later determination of the plasma renin activity. The main superior mesenteric artery was excised and bathed in Krebs bicarbonate solution (119 mM NaCl, 4.7 mM KCl, 1.18 mM KH 2 PO 4 , 1.18 mM MgSO 4 , 1.25 mM CaCl 2 , 25 mM NaHCO 3 , and 11 mM D-glucose, pH 7.4, 37°C) for dissection.
Blood Pressure Measurement. Systolic blood pressure and heart rate were measured in both conscious control rats and angiotensin II-treated rats by tail-cuff plethysmography connected to a computerized system (LE 5002; BIOSEB, Chaville, France). Rats were trained in the blood pressure device to accustom them to the procedure for 3 days before the osmotic minipump implantation. On each day of blood pressure determination, 10 measurements were obtained and averaged for each rat.
Determination of Plasma Renin Activity. Plasma renin activity was measured by determining the level of angiotensin I generated during a 30-min incubation of plasma at 37°C in the presence of 8-hydroxyquinoline (5 mM). Angiotensin I was measured by radioimmunoassay.
Vascular Reactivity Studies. The main superior mesenteric artery was cleaned of connective tissue and cut into rings (2-3 mm in length). Rings were suspended in organ baths containing oxygenated (95% O 2 , 5% CO 2 ) Krebs bicarbonate solution for the determination of changes in isometric tension. The rings were stretched step by step until an optimal resting tension of 1 g was reached and then allowed to equilibrate for at least 60 min. After the equilibration period, the rings were exposed to high K ϩ -containing Krebs bicarbonate solution (80 mM) until reproducible contractile responses were obtained. High K ϩ solution was prepared by equimolar substitution of NaCl with KCl. Thereafter, the rings were precontracted with phenylephrine (1 M) to approximately 80% of the maximal contraction to high K ϩ solution, and the relaxation to acetylcholine (1 M) was determined. After washout and a further 30-min equilibration period, rings were again contracted with phenylephrine (1 M) before a concentration-relaxation curve to acetylcholine (0.1 nM-10 M), RWPs (0.1-300 g/ml), sodium nitroprusside (0.1 nM-10 M), or levcromakalim (0.1 nM-10 M) was constructed. Sodium nitroprusside-and levcromakalim-induced relaxations were examined in endothelium-denuded rings of mesenteric artery. In some experiments, rings were exposed to an inhibitor for 45 to 120 min before contraction with phenylephrine. The NO-mediated component of relaxation was recorded in the presence of indomethacin (10 M) and charybdotoxin plus apamin (100 nM each) to rule out the formation of vasoactive prostanoids and EDHF, respectively. The EDHF-mediated component of relaxation was studied in the presence of indomethacin (10 M) and N -nitro-L-arginine (100 M) to rule out the formation of vasoactive prostanoids and NO, respectively. In some experiments, the relaxation was analyzed in the presence of all inhibitors [indomethacin, N -nitro-L-arginine, and charybdotoxin (100 nM) plus apamin (100 nM)]; the effect of this combination in which charybdotoxin was replaced with TRAM-34 (1 M) was also analyzed. In control experiments, the effect of a combination of indomethacin, N -nitro-L-arginine (300 M), carboxy-PTIO (300 M), and 1H-(1,2,4)-oxadiazolo(4,2-a)quinoxalin-1-one (ODQ, 1 M) was also investigated on EDHF-mediated relaxation. Relaxations were expressed as a percentage of the contraction induced by phenylephrine. Blood pressure measurement and vascular reactivity studies were also performed after only 14 days of angiotensin II administration (0.4 mg/kg/day).
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at ASPET Journals on April 1, 2017 jpet.aspetjournals.org Membrane Potential Measurement. Segments of the main superior mesenteric artery were slit open longitudinally and pinned to the sylgard base of a heated (37°C) organ chamber with the luminal side (endothelial layer) upward and superfused (5 ml/min) with heated (37°C) Krebs bicarbonate solution containing indomethacin (10 M) and N -nitro-L-arginine (100 M) to rule out the formation of vasoactive prostanoids and NO, respectively. The membrane potential of smooth muscle cells was recorded with glass capillary microelectrodes (tip resistance of 40 -80 M⍀) filled with KCl (3 mM) and connected to the head stage of a high-impedance amplifier (intra 767; World Precision Instruments, Inc., Sarasota, FL) as described previously (Chataigneau et al., 1998) ; an Ag/AgCl pellet, in contact with the bathing solution and directly connected to the amplifier, served as the reference electrode. Impalement of smooth muscle cells was performed from the intimal side, and successful impalements were signaled by a sudden negative drop in potential from the baseline (zero potential reference) to a stable negative potential for at least 2 min. The preparations were superfused for at least 60 min before any recording. All drugs were applied by continuous superfusion.
Immunohistochemical Determination of Connexin Distribution in the Mesenteric Arterial Wall. The main mesenteric artery was removed, embedded in ornithine carbamyl transferase compound, and snap-frozen. Frozen arteries were cryosectioned at 7 m. Sections were air-dried for 1 h and stored at Ϫ80°C until use. The slides were first treated with 5% goat serum in phosphatebuffered saline containing 0.1% Triton X-100 for 60 min to block any nonspecific binding. After rinsing, the sections were then incubated overnight at 4°C with the antibodies directed against connexins Cx37, Cx40, and Cx43 (dilutions from 1:100 to 1:200). Sections were then washed with phosphate-buffered saline, incubated with the secondary antibody (Alexa 488-conjugated goat anti-rabbit IgG; dilution, 1:200) diluted in the same buffer for 2 h at room temperature in the dark and washed before being mounted and coverslipped. For negative controls, primary antibodies were omitted.
The samples were observed using a confocal laser-scanning microscope (MRC-1024; Bio-Rad Laboratories, Hercules, CA) equipped with a krypton/argon laser and fitted with the appropriate filters for the detection of Alexa 488 fluorescence. Quantification of connexin expression was performed using Sharp 2000 software (Bio-Rad Laboratories).
Quantitative Real-Time RT-PCR Analysis. Total RNA was extracted from rat main mesenteric arteries using the Rneasy Micro KIT (QIAGEN S.A., Courtaboeuf, France). One microgram of total RNA was reverse transcribed by a modified Moloney murine leukemia virus-derived reverse transcriptase using the iScript cDNA synthesis kit according to the manufacture's instructions (Bio-Rad). Real-time PCR was performed using the protocol recommended for the iQ SYBR Green Supermix from Bio-Rad in a MyIQ thermocycler (Bio-Rad). Primers (Sigma Proligo; Sigma-Aldrich, St. Louis, MO) were designed with the help of the sequences of rat connexins deposited in GenBank (accession nos. M76532, AF021806, M19317, and BC087743 for Cx37, Cx40, Cx43, and GAPDH, respectively). The sequences of the primers were: rat Cx37, forward, 5Ј-TCGAGT-GTAACACAGCCCAG-3Ј and reverse, 5Ј-CCGCCGAGACAGGTA-AATGA-3Ј; rat Cx40, forward, 5Ј-TGCAGGAAAAGCAGAAGCTG-3Ј and reverse, 5Ј-GAGGACAATCTTCCCGTTCA-3Ј; rat Cx43, forward, 5Ј-GACTGCTTCCTCTCACGTC-3Ј and reverse, 5Ј-TTCACGC-GATCCTTAACGCC-3Ј; and GAPDH, forward, 5Ј-CCATCACCATCT-TCCAGGAG-3Ј and reverse, 5Ј-CGGAGATGATGACCCTTTTG-3Ј. The cycle conditions comprised a 3-min period of polymerase activation at 95°C and 42 cycles at 95°C for 15 s, 15 s at 59°C, and 10 s at 72°C. Analysis of DNA melting curves demonstrated a single peak for the whole set of primers. Amplification products were size controlled on a 2% gel agarose. Quantitative data were normalized relative to the internal housekeeping control GAPDH gene. Results are expressed as percentage of mRNA of connexins in angiotensin II-treated rats compared with untreated rats.
Preparation of RWPs. RWP dry powder, obtained from French red wine (Corbières A.O.C., France), was provided by Dr. M. Moutounet (Institut National de la Recherche Agronomique, Montpellier, France) and analyzed by Dr. P.-L. Teissedre (Dé partement d'Oenologie, Université de Montpellier, Montpellier, France). For the preparation of RWP dry powder, phenolic compounds were adsorbed on a preparative column, and alcohol was desorbed. The alcoholic eluent was gently evaporated, and the concentrated residue was lyophilized and finely sprayed to obtain RWP dry powder. One liter of red wines produced 2.9 g of RWPs, which contained 471 mg/g total phenolic compounds expressed as gallic acid. The extract contained 8.6 mg/g catechin, 8.7 mg/g epicatechin, dimers (B1, 6.9 mg/g; B2, 8.0 mg/g; B3, 20.7 mg/g; B4, 0.7 mg/g), anthocyanins (malvidin-3-glucoside, 11.7 mg/g; peonidin-3-glucoside, 0.66 mg/g; cyanidin-3-glucoside, 0.06 mg/g), and phenolic acids (gallic acid, 5.0 mg/g; caffeic acid, 2.5 mg/g; caftaric acid, 12.5 mg/g).
Materials. Antibodies were purchased as indicated: rabbit antirat connexin-37 polyclonal antibody (Alpha BioLab, Burlingame, CA), rabbit anti-mouse connexin-40 polyclonal antibody (Chemicon, Temecula, CA), rabbit anti-rat connexin-43 polyclonal antibody (Zymed Laboratories, South San Francisco, CA), and Alexa Fluor-488 labeled to goat anti-rabbit IgG (Molecular Probes, Carlsbad, CA).
Apamin and charybdotoxin were obtained from Latoxan (Valence, France). ODQ was from Tocris Bioscience (Bristol, UK). N -nitro-Larginine, indomethacin, acetylcholine, sodium nitroprusside, levcromakalim, wortmannin, 18␣-glycyrrhetinic acid, carbenoxolone, angiotensin II acetate human, phenylephrine, and carboxy-PTIO were all obtained from Sigma-Aldrich. The superoxide dismutase mimetic, Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP), was provided by Alexis Laboratories (San Diego, CA). TRAM-34 was a generous gift from Dr. Heike Wulff (University of California, Davis, CA).
RWPs were dissolved in a solution of ethanol and deionized water [50% (v/v)]. A stock solution of indomethacin was prepared in a sodium bicarbonate (10 mM) solution. A stock solution of 18␣-glycyrrhetinic acid and ODQ was prepared in absolute dimethyl sulfoxide. The other compounds were dissolved in deionized water. Concentrations are expressed as final concentrations (molar or micrograms per milliliter) in the bath solution. Alzet osmotic minipumps were purchased from Charles River Laboratories, Inc. (Wilmington, MA).
Statistical Analysis. Values are expressed as means Ϯ S.E.M., and n indicates the number of animals. Statistical analysis was performed with Student's t test for paired data or analysis of variance followed by Fischer's protected least significant difference test to compare two treatments where appropriate. Values of p Ͻ 0.05 were considered to be statistically significant.
Results
Characterization of Acetylcholine-and RWP-Induced EDHF-Mediated Relaxation in Mesenteric Arteries from
Control Rats. The cumulative addition of acetylcholine caused concentration-dependent relaxations in isolated mesenteric arteries from control rats, in the presence of indomethacin (10 M) and N -nitro-L-arginine (100 M) (Fig. 1) . These relaxations were abolished by the combination of apamin (100 nM) plus charybdotoxin (100 nM) and also by the combination of apamin (100 nM 
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The two different stimuli of EDHF-mediated responses, acetylcholine and RWPs, were then compared in mesenteric arteries from control rats, in the presence of indomethacin and N -nitro-L-arginine (Fig. 1) . Acetylcholine-induced EDHFmediated relaxation was not modified by MnTMPyP, a superoxide dismutase mimetic (Fig. 1A) , whereas this later compound abolished EDHF-mediated relaxation to RWPs (Fig. 1B) . Likewise, wortmannin, a PI3-kinase inhibitor, abolished EDHF-mediated relaxation induced by RWPs (Fig. 1D) without altering that to acetylcholine (Fig. 1C) .
Gap junctions, which are formed of connexins, have been shown to play a crucial role in electrical coupling in the arterial wall and also in EDHF-mediated responses, at least in some vascular beds (Griffith et al., 2004; Mather et al., 2005) . In isolated mesenteric arteries from control rats, 18␣-glycyrrhetinic acid, a well recognized inhibitor of gap junctional communication (Griffith et al., 2004) , induced an almost complete inhibition of both EDHF-mediated relaxation to acetylcholine ( Fig. 2A) and RWPs (Fig. 2B ) without altering relaxations evoked by either sodium nitroprusside (Fig.  2C) or levcromakalim (Fig. 2D) . Similar results were obtained with carbenoxolone (100 M; Fig. 3 ), a water-soluble hemisuccinate derivative of 18␤-glycyrrhetinic acid. Altogether, these results suggest that gap junctions are involved in EDHF signaling in mesenteric arteries.
Chronic Administration of Angiotensin II Induces Hypertension. Chronic administration of angiotensin II (0.4 mg/kg/day for 21 days) induced a significant increase in systolic blood pressure to a maximal value of 178.2 Ϯ 7.8 mm Hg (n ϭ 11) after 20 days in comparison with control rats (124.0 Ϯ 3.4 mm Hg, n ϭ 14) (Fig. 4A) . In contrast, heart rate was unaffected by angiotensin II treatment (Fig. 4A) . The angiotensin II-induced increased systolic blood pressure was associated with a pronounced reduction of the plasma renin activity (39.1 Ϯ 4.1 ng/Ang I/ml/h, n ϭ 14 and 7.2 Ϯ 1.7 ng/Ang I/ml/h, n ϭ 11 in control and angiotensin II-treated rats, respectively) (Fig. 4B) . The cumulative addition of acetylcholine caused concentration-dependent relaxations in isolated mesenteric arteries from both control and angiotensin II-treated rats (Fig. 5, A and C). The NO-mediated component of relaxation (Fig. 5A) was not significantly different in the vessels from the two groups of rats. In contrast, the EDHF-mediated component of relaxation (Fig. 5C ) was abolished in mesenteric artery rings from angiotensin II-treated rats. RWPs also caused concentration-dependent relaxations in isolated mesenteric arteries from the two groups of rats (Fig. 5, B and D) . Angiotensin II treatment was associated with an abolition of EDHF-mediated relaxation (Fig. 5D ) without significant alteration of NO-mediated relaxation (Fig. 5B) . In the presence of indomethacin, N -nitro-L-arginine, and charybdotoxin plus apamin, acetylcholine-and RWP-induced relaxations were abolished in both control rats and angiotensin II-teated rats (data not shown).
The angiotensin II treatment did not affect the concentration-dependent relaxation evoked by levcromakalim (0.1 nM-10 M), an ATP-sensitive K ϩ channel opener (pD 2 , 6.20 Ϯ 0.12 and 6.43 Ϯ 0.27 in mesenteric arteries from control and angiotensin II-treated rats, respectively; relaxant effect at 10 M, 87.5 Ϯ 4.0 and 90.2 Ϯ 7.2% in mesenteric arteries from control and angiotensin IItreated rats, respectively).
Altogether, these results indicate that the EDHF-mediated component of relaxation is selectively abolished by a chronic treatment with angiotensin II for 21 days. It is noteworthy that a chronic treatment with angiotensin II for 14 days (0.4 mg/kg/day) induced a significant increase in systolic blood pressure (170.7 Ϯ 6.8 versus 135.8 Ϯ 4.7 mm Hg, n ϭ 6, in angiotensin II-treated and control rats at day 14, respectively) without significant alteration in EDHF-mediated relaxations (data not shown).
Chronic Treatment with Angiotensin II for 21 Days Is Associated with an Inhibition of EDHF-Mediated Hyperpolarization in Rat Mesenteric Arteries ex Vivo.
The membrane potential of rat mesenteric smooth muscle cells was recorded with the intracellular microelectrode technique in the presence of indomethacin and N -nitro-L-arginine (Fig. 6) . Smooth muscle cells were significantly depolarized in arteries from rats treated with angiotensin II (resting membrane potential of Ϫ52.3 Ϯ 1.6 mV, n ϭ 7 and Ϫ46.8 Ϯ 1.6 mV, n ϭ 5, in mesenteric arteries from control and angiotensin II-treated rats, respectively). Acetylcholine-induced EDHF-mediated hyperpolarization, which averaged Ϫ18.3 Ϯ 2.5 mV (n ϭ 4) in mesenteric arteries from control rats, was significantly reduced in mesenteric arteries from angiotensin II-treated rats (Ϫ10.3 Ϯ 1.2 mV, n ϭ 3). As illustrated, RWPs elicited a slow-developing and long-lasting but transient hyperpolarization in mesenteric arteries from control rats (Ϫ15.0 Ϯ 1.7 mV, n ϭ 4; Fig. 6A ). This hyperpolarization was significantly and strongly reduced in mesenteric arteries from angiotensin II-treated rats (Ϫ5.0 Ϯ 1.0 mV, n ϭ 3; Fig. 6, A and B) . 
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Chronic Treatment with Angiotensin II Is Associated with a Reduced Expression of Cx37, Cx40, and Cx43 in the Rat Mesenteric Arterial Wall. Connexins Cx37, Cx40, and Cx43 represent the three major isoforms, which have been described in the vascular system . We have determined whether the expression of these three connexins is altered in the mesenteric arteries from angiotensin II-treated rats.
As shown in Fig. 7 , Cx37 and Cx43 were observed throughout the arterial wall in mesenteric arteries from control rats (Fig. 7, A and C) , whereas Cx40 was mainly detected in the endothelial layer (Fig. 7B) . The expression of the connexins was significantly reduced to 37.6 Ϯ 11.5, 35.2 Ϯ 8.8, and 42.6 Ϯ 7.2% of control value (100%) for Cx37, Cx40, and Cx43, respectively, in the mesenteric artery from angiotensin II-treated rats (Fig. 7A-C) .
The expression of the three connexins has also been assessed by mRNA analysis using quantitative real-time RT-PCR. As shown in Fig. 8 , the levels of mRNAs for Cx37, Cx40, and Cx43 were also significantly decreased in the mesenteric artery from angiotensin II-treated rats (reduction to 54.0 Ϯ 15.1, 44.1 Ϯ 9.4, and 44.3 Ϯ 13.6% of control value for Cx37, Cx40, and Cx43, respectively).
Discussion
The present findings demonstrate that chronic administration of angiotensin II induces hypertension in rats in association with a selective impairment of EDHF-mediated responses but without alteration of NO-mediated relaxation. This effect correlates with a decrease in Cx37, Cx40, and Cx43 expression, the three connexins that compose gap junctions in the mesenteric arterial wall.
As expected, chronic administration of angiotensin II induced hypertension in rats and a pronounced reduction of the plasma renin activity. This latter effect is indicative of a high impregnation of rats with angiotensin II and is probably because of a negative feedback control of angiotensin II on renin secretion (Tanabe et al., 1999) . Elevated plasma levels of angiotensin II are found in patients with severe forms of hypertension (Boyd et al., 1972; Sim and Qui, 2003) . There- fore, the experimental model of hypertension induced by angiotensin II is of potential clinical importance.
As shown in the present study, acetylcholine and RWPs induced both NO-and EDHF-mediated relaxation in the rat mesenteric artery. The NO-mediated component of relaxation was unaltered in mesenteric arteries from angiotensin II-treated rats. In contrast, in large elastic arteries such as aorta in which NO is the main endothelium-derived relaxing factor, chronic administration of angiotensin II induced a significant inhibition of NO-mediated relaxation (Sarr et al., 2006) . The decrease has been attributable, in part, to an increased vascular superoxide anion production, which inactivates NO. However, in agreement with our results, it has been observed that NO-mediated relaxation is not altered, whereas EDHF-mediated relaxation is significantly impaired in isolated mesenteric arteries from SHR in comparison with control rats (Onaka et al., 1998; Kähönen et al., 1999; Goto et al., 2000) . In summary, in hypertension, it seems that NOmediated responses are either decreased or unaltered (Félé-tou and Vanhoutte, 2004) .
Our study is the first to demonstrate that chronic in vivo administration of angiotensin II to rats is associated with a selective abolition of EDHF-mediated relaxation and a decreased EDHF-mediated hyperpolarization as assessed in the rat mesenteric artery ex vivo. Both abolition of EDHFmediated relaxation and reduction of EDHF-mediated hyperpolarization have been observed in mesenteric arteries from SHR in comparison with age-matched normotensive Wistar Kyoto (Fujii et al., 1992; Goto et al., 2000) . The restoration of these responses by an angiotensin-converting enzyme inhibitor, an angiotensin type 1 receptor antagonist, or their combination was already an indication of the negative influence of the renin-angiotensin system on EDHF-mediated responses (Onaka et al., 1998; Kähönen et al., 1999 , Goto et al., 2000 . However, none of these studies has demonstrated a relationship between administration of angiotensin II and EDHF. In our study, the absence of modification of NOmediated relaxation and levcromakalim-induced relaxation indicates that the treatment with angiotensin II does not alter the capacity of smooth muscle cells to relax or to hyperpolarize but is rather selective of EDHF signaling.
The present findings provide evidence that RWP-induced EDHF-mediated relaxation is sensitive to both MnTMPyP, a superoxide dismutase mimetic, and wortmannin, a PI3-kinase inhibitor, whereas acetylcholine-induced EDHF-mediated relaxation is unaffected by these two inhibitors in isolated mesenteric arteries from normotensive animals. These results strongly suggest that RWPs induce a redox-sensitive activation of the PI3-kinase/Akt pathway, leading to EDHFmediated relaxation in the rat mesenteric artery as previously demonstrated in the porcine coronary artery (Ndiaye et al., 2004) . The inhibition of EDHF-mediated relaxation by chronic administration of angiotensin II could be observed independently of the nature of the agonist (acetylcholine or RWPs), indicating that angiotensin II is not able to discriminate the two associated endothelial intracellular pathways. Therefore, a possible explanation is that chronic treatment with angiotensin II induces an alteration of a downstream endothelial mechanism, leading to EDHF-mediated relaxation of vascular smooth muscle, such as an alteration of the intercellular coupling by gap junctions.
Support for the hypothesis of a functional participation of gap junctions to EDHF-mediated responses has come from studies in which gap junctions were pharmacologically blocked, either with connexin-mimetic peptides or with glycyrrhetinic acid derivatives; 18␣-glycyrrhetinic acid is a well recognized inhibitor of gap junctional communication (Goldberg et al., 1996; Griffith et al., 2004) . In the present study, 18␣-glycyrrhetinic acid induced an almost complete blockade of acetylcholine-and RWP-induced EDHF-mediated relaxation without affecting sodium nitroprusside-and levcromakalim-induced relaxations. Therefore, our results are in agreement with previous studies showing that 18␣-glycyrrhetinic acid induces a significant inhibition of EDHF-mediated responses in the isolated, perfused or not, rat mesenteric artery (Harris et al., 2000; Goto et al., 2002) and confirm that gap junctions contribute to EDHF-mediated relaxation in this artery. The role of gap junctions is further supported by the data with carbenoxolone. In addition, our study provides evidence of participation of gap junctions in RWP-induced EDHF-mediated relaxation.
Our immunohistochemical data show that Cx37 and Cx43 are found both in the media and the intima, whereas Cx40 is mostly localized to the intima of mesenteric arteries from normotensive control rats (Kansui et al., 2004; Rummery and Hill, 2004; present study) . The present findings also demonstrate for the first time that chronic administration of angiotensin II down-regulates by approximately 50% of the expression of Cx37, Cx40, and Cx43 as assessed by quantitative real-time RT-PCR and by immunohistochemistry in crosssections from the main superior mesenteric arterial wall. Reduced EDHF-mediated responses are accompanied by an altered vascular expression of Cx37, Cx40, and Cx43 in arteries from hypertensive animals (Rummery and Hill, 2004) . The endothelial expression of Cx37, Cx40, and Cx43 is decreased in the caudal artery from the SHR compared with the Wistar Kyoto rat . However, it has been observed previously that the endothelial expression of Cx37 and Cx40 is reduced, whereas that of Cx43 is increased in mesenteric arteries from SHR in comparison with normotensive animals (Kansui et al., 2004) . A chronic treatment with candesartan, an angiotensin type 1 receptor antagonist, significantly increased the endothelial expression of Cx37 and Cx40 and decreased that of Cx43 (Kansui et al., 2004) . This apparent discrepancy with our study is probably related to the animal model or the cell types examined. Altogether, these data and the present findings strongly suggest that there is a close relationship between the renin-angiotensin system and vascular gap junctions and underline the major role of angiotensin II and/or hypertension in the control of connexin expression in vascular cells. There was a higher level of inhibition of EDHF-mediated relaxation in comparison with EDHF-mediated hyperpolarization, in response to chronic angiotensin II treatment. This difference could be explained by the fact that gap junctions seem to play a greater role in transmitting endothelial cell hyperpolarization to smooth muscle cells after depolarization with phenylephrine than under basal conditions (i.e., in the absence of stimulation with phenylephrine, a condition that was used in electrophysiological experiments in the present study) in mesenteric arteries (Edwards et al., 1999) . It is not known which connexins are precisely involved in EDHF-mediated responses. However, using a strategy to selectively load inhibitory connexin antibodies and peptides directed against Cx40 into endothelial cells, it has been shown recently that Cx40 is the critical connexin isoform involved in heterocellular signaling in rat mesenteric arteries (Mather et al., 2005) . Cx40 is probably the key connexin involved in EDHF-mediated responses and the conduction of vasodilatation in murine and rat arteries (de Wit et al., 2000; Figueroa et al., 2003; Mather et al., 2005) .
The exact cellular mechanisms by which connexin expression is decreased remain to be investigated. The role of reactive oxygen species on connexin expression should be examined because it is known that gap junctional communication is impaired by oxidative stress (Griffith et al., 2005) and that angiotensin II administration is associated with an increase in oxidative stress in arteries (Sarr et al., 2006) .
It has been observed that despite a reduced functional activity and expression of SK3 channels, the EDHF-mediated responses were not altered in small mesenteric arteries from rats treated with 60 ng/kg/min angiotensin II (Hilgers and Webb, 2007) . The absence of alteration of EDHF-mediated responses could be explained by the short duration of angiotensin II administration (14 days). We have also observed that a chronic treatment with angiotensin II for 14 days, even with a higher dose (0.4 mg/kg/day), induced a significant increase in systolic blood pressure without significant alteration in EDHF-mediated relaxations. Our results suggest that the inhibition of EDHF-mediated responses is a process that takes place in the long run after chronic exposure to angiotensin II or angiotensin II-induced hypertension (for at least 21 days).
In conclusion, our study highlights a close relationship among chronic exposure to angiotensin II, the abolition of EDHF-mediated relaxations, and the decrease in connexin expression in mesenteric arteries. Because EDHF is the predominant endothelial factor in small arteries, it is proposed that these latter modifications could well contribute to maintain and/or worsen hypertension.
